MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 134 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418,405 | -49.2% | 2,865 | -19.7% | 0.00% | -42.9% |
| Q2 2023 | $823,746 | -2.0% | 3,566 | +2.8% | 0.01% | -12.5% |
| Q1 2023 | $840,400 | -14.3% | 3,469 | +2.7% | 0.01% | -11.1% |
| Q4 2022 | $980,465 | +364.7% | 3,378 | +3.8% | 0.01% | +350.0% |
| Q3 2022 | $211,000 | -9.1% | 3,253 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $232,000 | -14.7% | 3,245 | +17.0% | 0.00% | 0.0% |
| Q1 2022 | $272,000 | +19.8% | 2,773 | +3.4% | 0.00% | 0.0% |
| Q4 2021 | $227,000 | +5.1% | 2,681 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $216,000 | -15.3% | 2,711 | +3.7% | 0.00% | 0.0% |
| Q2 2021 | $255,000 | -25.4% | 2,614 | -10.7% | 0.00% | -33.3% |
| Q1 2021 | $342,000 | +5.6% | 2,926 | +0.5% | 0.00% | 0.0% |
| Q4 2020 | $324,000 | -9.7% | 2,912 | -3.8% | 0.00% | -25.0% |
| Q3 2020 | $359,000 | +40.2% | 3,026 | +33.7% | 0.00% | 0.0% |
| Q2 2020 | $256,000 | – | 2,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |